L-arginine-mediated vasoreactivity in patients with a risk of stroke.
about
COPD and stroke: are systemic inflammation and oxidative stress the missing links?The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis--a case control pilot study.Cerebral endothelial function determined by cerebrovascular reactivity to L-arginine.Associations between cerebral and systemic endothelial function in migraine patients: a post-hoc studyL-arginine reactivity in cerebral vessels after severe traumatic brain injury.Endothelial function in migraine with aura - a systematic review.l-arginine and l-NMMA for assessing cerebral endothelial dysfunction in ischaemic cerebrovascular disease: A systematic review.Impaired hypoxic cerebral vasodilation in younger adults with metabolic syndrome.Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention.Traumatic Brain Injury Causes Endothelial Dysfunction in the Systemic Microcirculation through Arginase-1-Dependent Uncoupling of Endothelial Nitric Oxide Synthase.Cerebrovascular reactivity to L-arginine in patients with lacunar infarctions.Regulation of cerebral vascular function by sirtuin 1.Cerebrovascular Disease: Consequences of Obesity-Induced Endothelial Dysfunction.Endothelium-dependent vasodilatation in forearm is impaired in stroke patients.
P2860
Q26746530-74CEAB1E-5790-4FA2-93F2-D020B376C9C1Q30403470-D6CA9D0D-BAE0-41B5-BDBF-02195CFC0D7CQ30437977-2A5C0418-6802-4CB7-8541-3CFE426BEA9EQ30471524-1E672616-8151-4560-96A5-EC8E721A660FQ34217575-4B40DA5A-F162-4095-ACFF-8FA017C581D1Q35535243-DB74F8C8-B117-4583-81D8-AE8E637FAA59Q36153314-36FCDE39-E88B-4F26-97FF-213181FBD799Q37508034-9B85F50B-28FE-4F8A-B7BE-BE46233F0E7DQ37725077-27008D77-8995-4E27-A5CD-817330D2E285Q46611841-E54E5358-0DAF-4EC0-9ABA-010ED9EEE282Q46875503-E8073E96-42AB-49E1-B88C-18A631E7EC3CQ48669695-685A6876-4F36-4E8B-8DA9-5526DD0A6128Q49970492-DE1B798D-0047-4CA6-9640-AB7A6A3BCC0EQ50773075-43ACAAA9-F5CF-4D6C-A481-DC822967F0B3
P2860
L-arginine-mediated vasoreactivity in patients with a risk of stroke.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
L-arginine-mediated vasoreactivity in patients with a risk of stroke.
@en
L-arginine-mediated vasoreactivity in patients with a risk of stroke.
@nl
type
label
L-arginine-mediated vasoreactivity in patients with a risk of stroke.
@en
L-arginine-mediated vasoreactivity in patients with a risk of stroke.
@nl
prefLabel
L-arginine-mediated vasoreactivity in patients with a risk of stroke.
@en
L-arginine-mediated vasoreactivity in patients with a risk of stroke.
@nl
P2093
P356
P1476
L-arginine-mediated vasoreactivity in patients with a risk of stroke.
@en
P2093
Carolin Zimmermann
Martin Wimmer
Roman L Haberl
P304
P356
10.1159/000075781
P577
2003-12-23T00:00:00Z